May 11, 2007 (CIDRAP News) – The city of Edmonton, Alta., recently announced that it was stockpiling an herbal supplement in the hope of boosting the immunity of police, firefighters, and other essential workers during an influenza pandemic.By buying a ginseng product from CV Technologies, Inc., a company based in Edmonton, the city has become the first in North America to add an herbal supplement to its pandemic stockpile, according to media reports.The supplement, COLD-fX, is a proprietary extract of North American ginseng that contains what the company calls unique polysaccharide components. It is Canada’s top-selling over-the-counter cold and flu remedy, according to an Apr 23 company press release. Warren Michaels, CV Technologies’ vice president of media relations, told CIDRAP News the company launched COLD-fX in the United States in October 2006 and that sales have been modest.City says decision took timeBob Black, Edmonton’s director of emergency preparedness, said in the CV Technologies press release that COLD-fX is another tool the city can use for pandemic preparedness. “There are so many unknowns in planning for a possible pandemic that anything we can do to be prepared makes sense,” he said. “We need to take every reasonable precaution to help our emergency personnel stay on the job, so they can help others.”The stockpile will be used to treat 5,000 key city employees, such as police, firefighters, paramedics, and waste disposal workers. It consists of 600,000 pills, an 8-week supply, according to an Apr 25 report by the Toronto Globe and Mail.CV Technologies, which pitched the stockpiling idea to Edmonton’s pandemic planners, said it would split the $250,000 cost of the program with the city as part of the company’s social responsibility program. Black told CIDRAP News that the agreement stipulates that Edmonton will pay $30,000 up front to secure access to a stockpile of COLD-fX and will be required to pay its remaining share only if and when the city needs the remedy in a pandemic setting.The product has a 5-year shelf life, but the company said it would make sure the city has access to a fresh supply regardless of when it uses the stockpile.Jacqueline Shan, PhD, DSc, CV Technologies’ chief executive officer and chief scientific officer, said that in a pandemic, “COLD-fX may help provide additional protection to front line workers by enhancing their immune systems” until an effective vaccine becomes available.Black said the city spent more than a year considering if it should stockpile COLD-fX. Senior officials and an epidemiologist from the city’s occupational health and safety office were involved in the discussions. “It wasn’t a spur-of-the-moment decision. On the balance, it seemed like a prudent thing to do” he said.Emergency preparedness officials are faced with tough questions about whether workers, particularly those in health and public safety jobs, like paramedics, firefighters, and police, will come to work during a pandemic, Black said. Having an herbal remedy on hand that might boost immunity could potentially make employees feel more confident about showing up for work, he said.Canadian health officials may have a heightened sensitivity about protecting workers during a public health emergency because of their experience with SARS (severe acute respiratory syndrome) in 2003, Black said. A final report on the outbreak that was issued in January faulted hospital officials for not doing more to protect their workers; nine hospital workers in Toronto contracted SARS while caring for critically ill patients.Studies suggest possible benefitsSome randomized, double-blind, placebo-controlled studies have suggested that COLD-fX can help people reduce their number of colds and the duration and severity of symptoms.Two controlled trials were described in one report in the January 2004 issue of the Journal of the American Geriatrics Society. The researchers evaluated the effect of COLD-fX on the number of laboratory-confirmed acute respiratory illnesses in 198 nursing home and assisted-living residents (average ages, 83.5 and 81) in the 2000 and 2000-01 flu seasons.Ninety percent of the subjects had received the influenza vaccine. Half received a 200-mg COLD-fX tablet twice a day, while the others received placebo tablets.Investigators found that more people in the placebo group (9 of 101 subjects) than in the treatment group (1 of 97 subjects) were diagnosed with flu or respiratory syncytial virus. They calculated that the overall risk was reduced by 89% in the treatment group and concluded that COLD-fX was a safe, well-tolerated, and potentially effective treatment for preventing acute respiratory illnesses.During the 2003-04 cold and flu season, another research group, headed by Gerald N. Predy of the regional public health agency based in Edmonton, studied whether the ginseng supplement could prevent colds in a group of 323 Edmonton adults aged 18 to 85 who had not received seasonal flu vaccination. Their findings appeared in the October 2005 issue of the Canadian Medical Association Journal (CMAJ).The volunteers, who had a history of at least two colds the previous season, randomly received two COLD-fX capsules or a placebo daily for 4 months. Colds were verified by a symptom scoring system and graded on a 4-point severity scale.Researchers found that those who took COLD-fX had fewer colds and the colds they did have were milder and less persistent. The authors concluded that the treatment appeared to reduce the number of recurrent colds by almost 13%, the severity of colds by 15.4%, and the average duration of colds by 2.4 days.In a commentary published in the same issue of CMAJ, Ronald B. Turner, MD, professor of pediatrics at the University of Virginia School of Medicine in Charlottesville, wrote that problems with natural remedy studies typically include a lack of information about the active ingredients they contain, lack of a clear understanding of the mechanism of action, and lot-to-lot variability in the products. However, he said the COLD-fX was standardized to reduce such variability.Turner wrote that it was not clear how the effects of North American ginseng relate to viral respiratory infections. “Enhancement of interferon-gamma activity might be expected to reduce the severity of symptoms, but enhancement of the elaboration of inflammatory cytokines might be expected to increase the severity,” he wrote.Few rigorous, reproducible studies have shown either conventional or alternative cold treatments to be beneficial, Turner wrote. Further studies involving well-characterized and standardized ginseng preparations were needed to confirm the results of the CMAJ study, he stated.Public health experts weigh inPaula Steib, communications director for the Association of State and Territorial Health Officials (ASTHO) in Washington, DC, told CIDRAP News in an e-mail that it’s not surprising to see a metropolitan area like Edmonton stockpile a natural remedy. Canada, along with Australia, Britain, and other European countries, has a long tradition of using homeopathic and herbal remedies, which are available in pharmacies and often prescribed by physicians, she said.”The situation is very different in the US where most homeopathic and herbal remedies are scoffed at by the medical establishment,” Steib said. “ASTHO is unaware of any state that is stockpiling remedies that are not part of the CDC’s strategic national stockpile program.”Jeffrey Duchin, MD, chief of communicable disease control for Seattle King County Public Health in Washington, said Edmonton’s plan to stockpile COLD-fX for its essential employees sounded interesting, but he said it was unclear from the studies whether the remedy would be of value.”It appears safe and inexpensive, but it shows how little else people feel they have to turn to,” he said.Communities that consider adding an alternative remedy to their stockpiles should weigh the costs and benefits, Duchin said. If they have met other stockpiling needs, such as having adequate supplies of oseltamivir (Tamiflu) and personal protective equipment, and still have money left in their pandemic preparedness budgets, then it might be reasonable to consider adding something extra, he said.Black said the city has increased its supplies of personal protective equipment and other items its employees would need and noted that other public health functions, including stockpiling vaccines and antivirals, are handled by the province and its health authorities.NIH says ginseng may have potentialThe CMAJ study caught the attention of the US National Institutes of Health (NIH), which in September 2006 included it in its annual bibliography of significant advances in dietary supplement research. “These findings suggest that North American ginseng may be an attractive natural prophylactic for upper respiratory tract infections,” the NIH said. “Additional studies are needed to confirm these findings.”In January, the Nutrition Action Health Letter, a publication of the Center for Science in the Public Interest, a health advocacy group, included COLD-fX in a review of eight popular over-the-counter cold remedies. The publication said that more studies are needed to confirm that COLD-fX can shorten or prevent colds or flu. “Even so, COLD-fX is the only remedy we found with any evidence that it might improve your chances of getting through the cold and flu season without coming down with something,” the article said.Michaels said CV Technologies doesn’t want to overstate COLD-fX’s potential in a pandemic situation, but he said the company believes the product has merit and is a legitimate candidate for incorporation into pandemic plans.The company is exploring the possibility of applying for US Food and Drug Administration approval to market COLD-fX specifically as a preventive for colds and is conducting a phase 3 clinical trial for that purpose. The company also recently launched a trial to see if COLD-fX improves the immunity of healthcare workers and is investigating the precise biochemical pathways by which the product affects the immune system, according to information on the company’s Web site.See also:McElhaney JE, Gravenstein S, Cole SK, et al. A placebo controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc 2004 Jan;52(1):13-9 [Abstract]Predy GN, Goel V, Lovlin R, et al. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ 2005 Oct;173(9):1043-8 [Full text]Turner B. Studies of “natural” remedies for the common cold: pitfalls and pratfalls. (Commentary) CMAJ 2005 Oct 25;173(9):1051-2 [Full text]CV Technologies news releaseSARS Commission final reporthttp://www.ontla.on.ca/library/repository/mon/16000/268478.pdfNIH press releasehttp://www.nih.gov/news/pr/sep2006/od-21.htmNIH bibliographies of dietary supplement research advanceshttp://ods.od.nih.gov/Research/Annual_Bibliographies.aspxSchardt D. Un-catching colds: do popular remedies work? Nutrition Action Healthletter 2007 Jan/Feb;8-11 [Full text]
Indonesia’s loan growth fell to a more than 10-year low in February as a cooling economy due to the COVID-19 pandemic hit credit demand across business sectors.The country’s banking industry recorded a 5.93 percent loan growth in this year’s second month, the lowest expansion since November 2009, according to Financial Services Authority (OJK) data. The figure is lower than 6.1 percent booked in January.Non-performing loans (NPL) jumped to nearly 2.8 percent, the highest since May last year. “The slow loan growth was caused by weak demand in line with the economic cycle, which has been slowing since 2019’s fourth quarter,” said Bank Permata economist Josua Pardede on Thursday.Read also: Avoiding quarantine will inflict greater economic harm, says survey“Considering that the COVID-19 pandemic will slow down the domestic economy, particularly household spending and private investment, loan growth in 2020 is estimated to continue to be weak,” he added.The spread of the coronavirus has forced the government to call on citizens to stay home to contain the disease contagion, causing business disruptions and hitting people’s purchasing power. Official data show that COVID-19 had infected more than 1,986 people with 181 fatalities as of Friday afternoon. The government projects Indonesia’s economy to grow 2.3 percent this year under the baseline scenario, which would be the lowest rate since 1999, or contract by 0.4 percent in the worst-case scenario as the pandemic batters activity.Josua said the pandemic had significantly hit six sectors, namely the transportation, warehousing and communication sector, the accommodation, food and beverage sector, wholesale and retail trade, the agriculture, plantation and forestry sector, the mining sector and the processing industry sector.He projected Indonesia’s loan growth to reach between 4 and 6 percent this year compared to 6.08 percent in 2019. The OJK and Bank Indonesia previously set a loan growth target of around 11 percent this year. The central bank recently slashed its projection to between 6 and 8 percent.State-owned Bank Mandiri president director Royke Tumilaar said in a teleconferenced press briefing on Wednesday that the country’s second-largest bank by assets value would revise its loan growth, which was initially penciled at between 8 and 10 percent this year. However, he stopped short of mentioning the new figure.Read also: State firms to focus on ‘slimming down’ while avoiding layoffs“But this doesn’t mean there are no loan expansions. At certain times, [loan disbursements] will be very selective,” he said.He expressed hope that the bank could still maintain collectibility and keep NPL in check following a new OJK regulation that eases bank loan restructuring.The OJK relaxed debt quality assessment and restructuring requirements for debtors. Banks now only assess the quality of a loan worth up to Rp 10 billion (US$594,282) based on a debtor’s timeliness in paying the loan’s principal and interest. Previously, the banks also assessed the debtor’s business prospects and financial condition.Debtors who restructure their loans will get an improvement in their loan quality after the process and banks can implement such a policy for any loan amount, among other policies.The central bank, on the other hand, has also cut its benchmark interest rate twice so far this year by a total of 50 basis points (bps) to 4.5 percent to cushion the economy from impacts of the disease.While the benchmark rate cuts could potentially push down bank interest rates, its impact on loan growth would be limited as risks tended to increase, Josua argued.“Therefore, government stimulus like social safety nets, cash transfers and stimulus for the affected sectors, coupled with counter-cyclical and cyclical policies from the OJK as well as relaxations from BI, will boost economic activities after the COVID-19 pandemic ends,” he said, adding that all of these would ultimately push up loan growth.Meanwhile, Bank Mandiri chief economist Andry Asmoro was of the view that the impacts of the COVID-19 outbreak on the economy and banking industry remained uncertain.“Hence, banks will remain cautious about the affected sectors and will focus on managing asset quality,” he wrote in a statement made available to The Jakarta Post on Thursday.Topics :
Loading… Agent of departing Chelsea midfielder Willian admits a move to Arsenal is close. Willian announced he would be leaving Chelsea after seven years when his contract expires this August, and has reportedly already completed his medical at Arsenal. The Brazilian will put pen to paper on a three-year deal worth £150,000-a-week. Kia Joorabchian appeared to confirm this on talkSPORT, saying: “It won’t be long before we announce it. We know where he is going.”Advertisement read also:Arsenal boss Arteta promises Willian new role However, the agent also cooled talk of a deal with Arsenal for Sporting CP winger Joelson Fernandes. He added: “We have never ever spoken to him about Arsenal. It is so untrue.” FacebookTwitterWhatsAppEmail分享 Promoted Content6 Incredibly Strange Facts About HurricanesWho Is The Most Powerful Woman On Earth?7 Ways To Understand Your Girlfriend BetterThe Models Of Paintings Whom The Artists Were Madly In Love WithCouples Who Celebrated Their Union In A Unique, Unforgettable Way9 Facts You Should Know Before Getting A TattooThe Most Clever Uses Of CGI In CinemaPortuguese Street Artist Creates Hyper-Realistic 3D Graffiti2020 Tattoo Trends: Here’s What You’ll See This YearTop 10 Most Romantic Nations In The WorldA Hurricane Can Be As Powerful As 10 Atomic Bombs10 Risky Jobs Some Women Do
Fuzhou: India’s men’s doubles pair of Satwiksairaj Rankireddy and Chirag Shetty on Thursday stunned sixth seed Hiroyuki Endo and Yuta Watanabe of Japan to enter the quarterfinals of the China Open in Fuzhou. Rankireddy and Shetty played their hearts out to get the better of their Japanese opponents 21-18 21-23 21-11 in a pulsating second round contest that lasted an hour and six minutes. For Rankireddy and Shetty, who had reached the French Open final last month, the latest win is their second straight over Endo and Watanabe. The Indians had defeated the Japanese duo in straight games in Paris last month. Rankireddy and Shetty will face Li Jun Hui and Liu Yu Chen of China in the quarterfinals on Friday. Rankireddy and Shetty were the lone Indians left in the tournament after the others bite the dust on Thursday. Parupalli Kashyap and B Sai Praneeth were both ousted in the second round of the men’s singles event. World No. 11 Praneeth fought hard for one hour 24 minutes against fourth seed Anders Antonsen of Denmark before going down 20-22 22-20 21-16. Kashyap, ranked 25 in the world, ran out of steam after a decent start against seventh seed Victor Axelsen and went down 13-21 19-21 in a match that lasted 43 minutes. Praneeth’s loss marked the end of India’s campaign in the singles. Also Read | Satwiksairaj Rankireddy and Chirag Shetty enter top 10 of world doubles ranking in BadmintonThis is the second time Kashyap had lost to Axelsen this year. The former Commonwealth Games champion, who reached the semifinals of India Open and Korea Open earlier this year, had lost to the world number six at the India Open in March. It was also the end of the road for the mixed doubles pair of Rankireddy and Ashwini Ponnappa. The unseeded Indian duo lost 21-23 16-21 to fifth seeds Seo Seung Jae and Chae Yujung of South Korea. For all the Latest Sports News News, Other Sports News, Download News Nation Android and iOS Mobile Apps.
“This is a really important game for us. So far we only have one point in the group and against Malaysia, we have to get three points. We went to Singapore to play a friendly game, it’s still early in the season for us so everyone is still finding our match fitness. But after training for a week, everyone look sharp and ready for the game,” said Tan.Tan is only one of three players in the squad that Kim has called up for this round of international fixtures as the latter seek to rely on experience to help them in Tuesday’s match at Hang Jebat Stadium. Asian Cup Qualification Hong Kong confident of besting Malaysia in Asian Cup qualifier Ooi Kin Fai Last updated 2 years ago 09:15 9/4/17 FacebookTwitterRedditcopy Comments(0) Goal Asian Cup Qualification Malaysia v Hong Kong Malaysia Hong Kong Kim Pan-Gon is urging his Hong Kong side to take the initiative against Malaysia in Tuesday’s Asian Cup qualifier match. Hong Kong are eyeing the Group B match against Malaysia in the Asian Cup qualifier as a potential three points in the bag as they look to make inroads towards reaching the finals in United Arab Emirates in 2019.After a slow start in which they lost to Lebanon in their opening fixture in the group, Hong Kong caused a major upset as they held North Korea to a 1-1 draw in June. With a point in the bag, head coach Kim Pan-Gon is urging his side to take control of Tuesday’s match against Malaysia and increased their points tally in the group. Editors’ Picks Brazil, beware! Messi and Argentina out for revenge after Copa controversy Best player in MLS? Zlatan wasn’t even the best player in LA! ‘I’m getting better’ – Can Man Utd flop Fred save his Old Trafford career? Why Barcelona god Messi will never be worshipped in the same way in Argentina “Yes, Hong Kong are the favourites. We are proactive and we try to dominate, we are an attacking side,” said Kim in the pre-match press conference on Monday.The 48-year-old South Korean has been in charge of Hong Kong national team since 2012 and has faced Malaysia a fair few times. Despite not winning a single one of the three matches that he has played against Malaysia, Kim remains very confdent heading into the fixture. He is labelled Malaysia as a less attractive opposition these days.”Since I in charge of the national team, twice I came here to play with them. We drew two times. Quite impressed always, players skillful and aggressive. Very attacking side, really struggle for us last two games. But current team become more reactive, more defensive and less attractive. Something different than before,” he added.Meanwhile young midfielder Tan Chun Lok says his team is ready to face Malaysia despite their domestic season in Hong Kong still being in its infancy months. The former Peterbrough United and Northampton Town player warns that his team are slowly but surely finding their feet again.